BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ruiz-Ortega M, Rayego-Mateos S, Lamas S, Ortiz A, Rodrigues-Diez RR. Targeting the progression of chronic kidney disease. Nat Rev Nephrol 2020;16:269-88. [PMID: 32060481 DOI: 10.1038/s41581-019-0248-y] [Cited by in Crossref: 74] [Cited by in F6Publishing: 73] [Article Influence: 37.0] [Reference Citation Analysis]
Number Citing Articles
1 Ding B, Ma G, Wang Z, Liang W, Gao W. Mechanisms of Kidney Cell Pyroptosis in Chronic Kidney Disease and the Effects of Traditional Chinese Medicine. Evid Based Complement Alternat Med 2021;2021:1173324. [PMID: 34671403 DOI: 10.1155/2021/1173324] [Reference Citation Analysis]
2 Li CM, Li M, Zhao WB, Ye ZC, Peng H. Alteration of N6-Methyladenosine RNA Profiles in Cisplatin-Induced Acute Kidney Injury in Mice. Front Mol Biosci 2021;8:654465. [PMID: 34307448 DOI: 10.3389/fmolb.2021.654465] [Reference Citation Analysis]
3 Zou H, Xu Y, Meng X, Li D, Chen X, Du T, Yang Y, Chen Y, Shao S, Yuan G, Zhou X, Hu S, He W, Ma D, Xie J, Zhang B, Zhang J, Li W, Liu Z, Yu X. Circulating ANGPTL8 levels and risk of kidney function decline: Results from the 4C Study. Cardiovasc Diabetol 2021;20:127. [PMID: 34167540 DOI: 10.1186/s12933-021-01317-3] [Reference Citation Analysis]
4 Nowak N, Yamanouchi M, Satake E. The Nephroprotective Properties of Extracellular Vesicles in Experimental Models of Chronic Kidney Disease: a Systematic Review. Stem Cell Rev Rep 2021. [PMID: 34110587 DOI: 10.1007/s12015-021-10189-9] [Reference Citation Analysis]
5 Wang M, Wang L, Zhou Y, Feng X, Ye C, Wang C. Icariin attenuates renal fibrosis in chronic kidney disease by inhibiting interleukin-1β/transforming growth factor-β-mediated activation of renal fibroblasts. Phytother Res 2021. [PMID: 34426999 DOI: 10.1002/ptr.7256] [Reference Citation Analysis]
6 Cantero-Navarro E, Rayego-Mateos S, Orejudo M, Tejedor-Santamaria L, Tejera-Muñoz A, Sanz AB, Marquez-Exposito L, Marchant V, Santos-Sanchez L, Egido J, Ortiz A, Bellon T, Rodrigues-Diez RR, Ruiz-Ortega M. Role of Macrophages and Related Cytokines in Kidney Disease. Front Med (Lausanne) 2021;8:688060. [PMID: 34307414 DOI: 10.3389/fmed.2021.688060] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Noels H, Jankowski J. Editorial on the Special Issue "Comorbidities in Chronic Kidney Disease". Toxins (Basel) 2020;12:E384. [PMID: 32545170 DOI: 10.3390/toxins12060384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Wilke RA, Larson EA. Air, Land, and Sea: Gene-Environment Interaction in Chronic Disease. Am J Med 2021:S0002-9343(21)00483-6. [PMID: 34343516 DOI: 10.1016/j.amjmed.2021.07.006] [Reference Citation Analysis]
9 Samarakoon R, Higgins PJ. Editorial: Premature Aging and Senescence in Renal Fibrosis. Front Pharmacol 2021;12:734892. [PMID: 34381371 DOI: 10.3389/fphar.2021.734892] [Reference Citation Analysis]
10 Yan MT, Chao CT, Lin SH. Chronic Kidney Disease: Strategies to Retard Progression. Int J Mol Sci 2021;22:10084. [PMID: 34576247 DOI: 10.3390/ijms221810084] [Reference Citation Analysis]
11 Han Y, Zhang J, Huang S, Cheng N, Zhang C, Li Y, Wang X, Liu J, You B, Du J. MicroRNA-223-3p inhibits vascular calcification and the osteogenic switch of vascular smooth muscle cells. J Biol Chem 2021;296:100483. [PMID: 33647318 DOI: 10.1016/j.jbc.2021.100483] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Chen F, Xie Y, Lv Q, Zou W, Xiong L. Curcumin mediates repulsive guidance molecule B (RGMb) in the treatment mechanism of renal fibrosis induced by unilateral ureteral obstruction. Ren Fail 2021;43:1496-505. [PMID: 34751624 DOI: 10.1080/0886022X.2021.1997764] [Reference Citation Analysis]
13 Zhang J, Song K, Ping J, Du J, Sun Y, Zhang J, Qi M, Miao Y, Li Y. A biodegradable bismuth–gadolinium-based nano contrast agent for accurate identification and imaging of renal insufficiency in vivo. Inorg Chem Front 2021;8:4720-9. [DOI: 10.1039/d1qi00878a] [Reference Citation Analysis]
14 Zhu M, Ma L, Yang W, Tang L, Li H, Zheng M, Mou S. Elastography ultrasound with machine learning improves the diagnostic performance of traditional ultrasound in predicting kidney fibrosis. J Formos Med Assoc 2021:S0929-6646(21)00387-9. [PMID: 34452784 DOI: 10.1016/j.jfma.2021.08.011] [Reference Citation Analysis]
15 Xu M, Li S, Wang J, Huang S, Zhang A, Zhang Y, Gu W, Yu X, Jia Z. Cilomilast Ameliorates Renal Tubulointerstitial Fibrosis by Inhibiting the TGF-β1-Smad2/3 Signaling Pathway. Front Med (Lausanne) 2020;7:626140. [PMID: 33553218 DOI: 10.3389/fmed.2020.626140] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Giordano L, Mihaila SM, Eslami Amirabadi H, Masereeuw R. Microphysiological Systems to Recapitulate the Gut-Kidney Axis. Trends Biotechnol 2021;39:811-23. [PMID: 33419585 DOI: 10.1016/j.tibtech.2020.12.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Miguel V, Ramos R, García-Bermejo L, Rodríguez-Puyol D, Lamas S. The program of renal fibrogenesis is controlled by microRNAs regulating oxidative metabolism. Redox Biol 2021;40:101851. [PMID: 33465566 DOI: 10.1016/j.redox.2020.101851] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Chen S, Chen J, Li S, Guo F, Li A, Wu H, Chen J, Pan Q, Liao S, Liu HF, Pan Q. High-Fat Diet-Induced Renal Proximal Tubular Inflammatory Injury: Emerging Risk Factor of Chronic Kidney Disease. Front Physiol 2021;12:786599. [PMID: 34950058 DOI: 10.3389/fphys.2021.786599] [Reference Citation Analysis]
19 Nakano T, Watanabe H, Imafuku T, Tokumaru K, Fujita I, Arimura N, Maeda H, Tanaka M, Matsushita K, Fukagawa M, Maruyama T. Indoxyl Sulfate Contributes to mTORC1-Induced Renal Fibrosis via The OAT/NADPH Oxidase/ROS Pathway. Toxins 2021;13:909. [DOI: 10.3390/toxins13120909] [Reference Citation Analysis]
20 Hong S, Healy H, Kassianos AJ. The Emerging Role of Renal Tubular Epithelial Cells in the Immunological Pathophysiology of Lupus Nephritis. Front Immunol 2020;11:578952. [PMID: 33072122 DOI: 10.3389/fimmu.2020.578952] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
21 Xie T, Xia Z, Wang W, Zhou X, Xu C. BMPER Ameliorates Renal Fibrosis by Inhibiting Tubular Dedifferentiation and Fibroblast Activation. Front Cell Dev Biol 2021;9:608396. [PMID: 33644047 DOI: 10.3389/fcell.2021.608396] [Reference Citation Analysis]
22 Liu B, Jiang J, Liang H, Xiao P, Lai X, Nie J, Yu W, Gao Y, Wen S. Natural killer T cell/IL-4 signaling promotes bone marrow-derived fibroblast activation and M2 macrophage-to-myofibroblast transition in renal fibrosis. Int Immunopharmacol 2021;98:107907. [PMID: 34243040 DOI: 10.1016/j.intimp.2021.107907] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Xu J, Zhou L, Liu Y. Cellular Senescence in Kidney Fibrosis: Pathologic Significance and Therapeutic Strategies. Front Pharmacol 2020;11:601325. [PMID: 33362554 DOI: 10.3389/fphar.2020.601325] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
24 Shao M, Ye C, Bayliss G, Zhuang S. New Insights Into the Effects of Individual Chinese Herbal Medicines on Chronic Kidney Disease. Front Pharmacol 2021;12:774414. [PMID: 34803715 DOI: 10.3389/fphar.2021.774414] [Reference Citation Analysis]
25 Che YH, Xu ZR, Ni LL, Dong XX, Yang ZZ, Yang ZB. Isolation and identification of the components in Cybister chinensis Motschulsky against inflammation and their mechanisms of action based on network pharmacology and molecular docking. J Ethnopharmacol 2022;285:114851. [PMID: 34808299 DOI: 10.1016/j.jep.2021.114851] [Reference Citation Analysis]
26 Larraufie MH, Gao X, Xia X, Devine PJ, Kallen J, Liu D, Michaud G, Harsch A, Savage N, Ding J, Tan K, Mihalic M, Roggo S, Canham SM, Bushell SM, Krastel P, Gao J, Izaac A, Altinoglu E, Lustenberger P, Salcius M, Harbinski F, Williams ET, Zeng L, Loureiro J, Cong F, Fryer CJ, Klickstein L, Tallarico JA, Jain RK, Rothman DM, Wang S. Phenotypic screen identifies calcineurin-sparing FK506 analogs as BMP potentiators for treatment of acute kidney injury. Cell Chem Biol 2021:S2451-9456(21)00156-2. [PMID: 33894161 DOI: 10.1016/j.chembiol.2021.04.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Marquez-Exposito L, Tejedor-Santamaria L, Santos-Sanchez L, Valentijn FA, Cantero-Navarro E, Rayego-Mateos S, Rodrigues-Diez RR, Tejera-Muñoz A, Marchant V, Sanz AB, Ortiz A, Goldschmeding R, Ruiz-Ortega M. Acute Kidney Injury is Aggravated in Aged Mice by the Exacerbation of Proinflammatory Processes. Front Pharmacol 2021;12:662020. [PMID: 34239439 DOI: 10.3389/fphar.2021.662020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 Schmidt IM, Colona MR, Kestenbaum BR, Alexopoulos LG, Palsson R, Srivastava A, Liu J, Stillman IE, Rennke HG, Vaidya VS, Wu H, Humphreys BD, Waikar SS; Kidney Precision Medicine Project (KPMP). Cadherin-11, Sparc-related modular calcium binding protein-2, and Pigment epithelium-derived factor are promising non-invasive biomarkers of kidney fibrosis. Kidney Int 2021;100:672-83. [PMID: 34051265 DOI: 10.1016/j.kint.2021.04.037] [Reference Citation Analysis]
29 Le G, Yang L, Du H, Hou L, Ge L, Sylia A, Muhmood A, Chen X, Han B, Huang K. Combination of zinc and selenium alleviates ochratoxin A-induced fibrosis via blocking ROS-dependent autophagy in HK-2 cells. J Trace Elem Med Biol 2022;69:126881. [PMID: 34751137 DOI: 10.1016/j.jtemb.2021.126881] [Reference Citation Analysis]
30 Thomas MC. Targeting the Pathobiology of Diabetic Kidney Disease. Adv Chronic Kidney Dis 2021;28:282-9. [PMID: 34922684 DOI: 10.1053/j.ackd.2021.07.001] [Reference Citation Analysis]
31 Stone RC, Chen V, Burgess J, Pannu S, Tomic-Canic M. Genomics of Human Fibrotic Diseases: Disordered Wound Healing Response. Int J Mol Sci 2020;21:E8590. [PMID: 33202590 DOI: 10.3390/ijms21228590] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
32 Zhou Y, Yang X, Liu H, Luo W, Liu H, Lv T, Wang J, Qin J, Ou S, Chen Y. Value of [68Ga]Ga-FAPI-04 imaging in the diagnosis of renal fibrosis. Eur J Nucl Med Mol Imaging 2021;48:3493-501. [PMID: 33829416 DOI: 10.1007/s00259-021-05343-x] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Hirohama D, Kawarazaki W, Nishimoto M, Ayuzawa N, Marumo T, Shibata S, Fujita T. PGI2 Analog Attenuates Salt-Induced Renal Injury through the Inhibition of Inflammation and Rac1-MR Activation. Int J Mol Sci 2020;21:E4433. [PMID: 32580367 DOI: 10.3390/ijms21124433] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
34 Xue K, Wang Y, Wang Y, Fang H. Advanced Oxidation Protein Product Promotes Oxidative Accentuation in Renal Epithelial Cells via the Soluble (Pro)renin Receptor-Mediated Intrarenal Renin-Angiotensin System and Nox4-H2O2 Signaling. Oxid Med Cell Longev 2021;2021:5710440. [PMID: 34873430 DOI: 10.1155/2021/5710440] [Reference Citation Analysis]
35 Prat-Duran J, Pinilla E, Nørregaard R, Simonsen U, Buus NH. Transglutaminase 2 as a novel target in chronic kidney disease - Methods, mechanisms and pharmacological inhibition. Pharmacol Ther 2021;222:107787. [PMID: 33307141 DOI: 10.1016/j.pharmthera.2020.107787] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Maremonti F, Meyer C, Linkermann A. Mechanisms and Models of Kidney Tubular Necrosis and Nephron Loss. J Am Soc Nephrol 2022:ASN. [PMID: 35022311 DOI: 10.1681/ASN.2021101293] [Reference Citation Analysis]
37 Jia NY, Liu XZ, Zhang Z, Zhang H. Weighted Gene Co-expression Network Analysis Reveals Different Immunity but Shared Renal Pathology Between IgA Nephropathy and Lupus Nephritis. Front Genet 2021;12:634171. [PMID: 33854525 DOI: 10.3389/fgene.2021.634171] [Reference Citation Analysis]
38 Gu YY, Dou JY, Huang XR, Liu XS, Lan HY. Transforming Growth Factor-β and Long Non-coding RNA in Renal Inflammation and Fibrosis. Front Physiol 2021;12:684236. [PMID: 34054586 DOI: 10.3389/fphys.2021.684236] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Abu-Zaid A, Magzoub D, Aldehami MA, Behiry AA, Bhagavathula AS, Hajji R. The Effect of Iron Supplementation on FGF23 in Chronic Kidney Disease Patients: a Systematic Review and Time-Response Meta-Analysis. Biol Trace Elem Res 2021. [PMID: 33462793 DOI: 10.1007/s12011-021-02598-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Ebert T, Pawelzik SC, Witasp A, Arefin S, Hobson S, Kublickiene K, Shiels PG, Bäck M, Stenvinkel P. Inflammation and Premature Ageing in Chronic Kidney Disease. Toxins (Basel) 2020;12:E227. [PMID: 32260373 DOI: 10.3390/toxins12040227] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 12.0] [Reference Citation Analysis]
41 Wu J, Shi Z, Zhang Y, Yan J, Shang F, Wang Y, Lu H, Gu H, Dou W, Wang X, Yuan L. Native T1 Mapping in Assessing Kidney Fibrosis for Patients With Chronic Glomerulonephritis. Front Med (Lausanne) 2021;8:772326. [PMID: 34733870 DOI: 10.3389/fmed.2021.772326] [Reference Citation Analysis]
42 Yamamoto H, Ichikawa Y, Hirano SI, Sato B, Takefuji Y, Satoh F. Molecular Hydrogen as a Novel Protective Agent against Pre-Symptomatic Diseases. Int J Mol Sci 2021;22:7211. [PMID: 34281264 DOI: 10.3390/ijms22137211] [Reference Citation Analysis]
43 Wu L, Rong C, Zhou Q, Zhao X, Zhuansun XM, Wan S, Sun MM, Wang SL. Bone Marrow Mesenchymal Stem Cells Ameliorate Cisplatin-Induced Renal Fibrosis via miR-146a-5p/Tfdp2 Axis in Renal Tubular Epithelial Cells. Front Immunol 2020;11:623693. [PMID: 33664736 DOI: 10.3389/fimmu.2020.623693] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Li M, Yan Y, He J, Wang YM, Guo YX, Wang ZX, Zhang WK, Zhang HJ, Xu JK. Jolkinolide B alleviates renal fibrosis via anti-inflammation and inhibition of epithelial-mesenchymal transition in unilateral ureteral obstruction mice. J Asian Nat Prod Res 2022;24:76-87. [PMID: 34937462 DOI: 10.1080/10286020.2021.2016715] [Reference Citation Analysis]
45 Sandokji I, Greenberg JH. Plasma and Urine Biomarkers of CKD: A Review of Findings in the CKiD Study. Semin Nephrol 2021;41:416-26. [PMID: 34916002 DOI: 10.1016/j.semnephrol.2021.09.003] [Reference Citation Analysis]
46 Fu H, Gui Y, Liu S, Wang Y, Bastacky SI, Qiao Y, Zhang R, Bonin C, Hargis G, Yu Y, Kreutzer DL, Biswas PS, Zhou Y, Wang Y, Tian XJ, Liu Y, Zhou D. The hepatocyte growth factor/c-met pathway is a key determinant of the fibrotic kidney local microenvironment. iScience 2021;24:103112. [PMID: 34622165 DOI: 10.1016/j.isci.2021.103112] [Reference Citation Analysis]
47 Lan F, Zhu C, Jin R, Zhou L, Hu Y, Zhao J, Xu S, Xia Y, Li W. Clinical characteristics of COVID-19 patients with complications: implications for management. Ther Adv Chronic Dis 2021;12:20406223211041924. [PMID: 34729141 DOI: 10.1177/20406223211041924] [Reference Citation Analysis]
48 Ke Q, Shi C, Lv Y, Wang L, Luo J, Jiang L, Yang J, Zhou Y. SGLT2 inhibitor counteracts NLRP3 inflammasome via tubular metabolite itaconate in fibrosis kidney. FASEB J 2022;36:e22078. [PMID: 34918381 DOI: 10.1096/fj.202100909RR] [Reference Citation Analysis]
49 Lavoz C, Rodrigues-Diez RR, Plaza A, Carpio D, Egido J, Ruiz-Ortega M, Mezzano S. VEGFR2 Blockade Improves Renal Damage in an Experimental Model of Type 2 Diabetic Nephropathy. J Clin Med 2020;9:E302. [PMID: 31973092 DOI: 10.3390/jcm9020302] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
50 Chung YH, Kuo HC, Liu HY, Wu MY, Chang WJ, Chen JT, Cherng YG, Chen TJ, Dai YX, Wu HL, Liu WC, Tai YH. Association between Dental Scaling and Reduced Risk of End-Stage Renal Disease: A Nationwide Matched Cohort Study. Int J Environ Res Public Health 2021;18:8910. [PMID: 34501499 DOI: 10.3390/ijerph18178910] [Reference Citation Analysis]
51 Klaus R, Niyazi M, Lange-Sperandio B. Radiation-induced kidney toxicity: molecular and cellular pathogenesis. Radiat Oncol 2021;16:43. [PMID: 33632272 DOI: 10.1186/s13014-021-01764-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
52 Miyano T, Suzuki A, Sakamoto N. Hyperosmotic stress induces epithelial-mesenchymal transition through rearrangements of focal adhesions in tubular epithelial cells. PLoS One 2021;16:e0261345. [PMID: 34932568 DOI: 10.1371/journal.pone.0261345] [Reference Citation Analysis]
53 El-Rashid M, Nguyen-Ngo D, Minhas N, Meijles DN, Li J, Ghimire K, Julovi S, Rogers NM. Repurposing of metformin and colchicine reveals differential modulation of acute and chronic kidney injury. Sci Rep 2020;10:21968. [PMID: 33319836 DOI: 10.1038/s41598-020-78936-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
54 Ou SM, Tsai MT, Chen HY, Li FA, Tseng WC, Lee KH, Chang FP, Lin YP, Yang RB, Tarng DC. Identification of Galectin-3 as Potential Biomarkers for Renal Fibrosis by RNA-Sequencing and Clinicopathologic Findings of Kidney Biopsy. Front Med (Lausanne) 2021;8:748225. [PMID: 34869439 DOI: 10.3389/fmed.2021.748225] [Reference Citation Analysis]
55 Shabaka A, Cases-Corona C, Fernandez-Juarez G. Therapeutic Insights in Chronic Kidney Disease Progression. Front Med (Lausanne) 2021;8:645187. [PMID: 33708784 DOI: 10.3389/fmed.2021.645187] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Li Y, Guo F, Huang R, Ma L, Fu P. Natural flavonoid pectolinarigenin alleviated kidney fibrosis via inhibiting the activation of TGFβ/SMAD3 and JAK2/STAT3 signaling. Int Immunopharmacol 2021;91:107279. [PMID: 33340783 DOI: 10.1016/j.intimp.2020.107279] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
57 Taguchi S, Azushima K, Yamaji T, Urate S, Suzuki T, Abe E, Tanaka S, Tsukamoto S, Kamimura D, Kinguchi S, Yamashita A, Wakui H, Tamura K. Effects of tumor necrosis factor-α inhibition on kidney fibrosis and inflammation in a mouse model of aristolochic acid nephropathy. Sci Rep 2021;11:23587. [PMID: 34880315 DOI: 10.1038/s41598-021-02864-1] [Reference Citation Analysis]
58 Stein MC, Braun F, Krebs CF, Bunders MJ. Kidney organoid systems for studies of immune-mediated kidney diseases: challenges and opportunities. Cell Tissue Res 2021. [PMID: 34309728 DOI: 10.1007/s00441-021-03499-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Liu Y, Chen DQ, Han JX, Zhao TT, Li SJ. A Review of Traditional Chinese Medicine in Treating Renal Interstitial Fibrosis via Endoplasmic Reticulum Stress-Mediated Apoptosis. Biomed Res Int 2021;2021:6667791. [PMID: 34055995 DOI: 10.1155/2021/6667791] [Reference Citation Analysis]
60 Lim WTH, Ooi EH, Foo JJ, Ng KH, Wong JHD, Leong SS. Shear Wave Elastography: A Review on the Confounding Factors and Their Potential Mitigation in Detecting Chronic Kidney Disease. Ultrasound Med Biol 2021;47:2033-47. [PMID: 33958257 DOI: 10.1016/j.ultrasmedbio.2021.03.030] [Reference Citation Analysis]
61 Potter JA, Price GW, Cliff CL, Green CR, Squires PE, Hills CE. Collagen I Modifies Connexin-43 Hemichannel Activity via Integrin α2β1 Binding in TGFβ1-Evoked Renal Tubular Epithelial Cells. Int J Mol Sci 2021;22:3644. [PMID: 33807408 DOI: 10.3390/ijms22073644] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
62 Shao BY, Zhang SF, Li HD, Meng XM, Chen HY. Epigenetics and Inflammation in Diabetic Nephropathy. Front Physiol 2021;12:649587. [PMID: 34025445 DOI: 10.3389/fphys.2021.649587] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
63 Pavlov TS, Palygin O, Isaeva E, Levchenko V, Khedr S, Blass G, Ilatovskaya DV, Cowley AW Jr, Staruschenko A. NOX4-dependent regulation of ENaC in hypertension and diabetic kidney disease. FASEB J 2020;34:13396-408. [PMID: 32799394 DOI: 10.1096/fj.202000966RR] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
64 Cantero-Navarro E, Fernández-Fernández B, Ramos AM, Rayego-Mateos S, Rodrigues-Diez RR, Sánchez-Niño MD, Sanz AB, Ruiz-Ortega M, Ortiz A. Renin-angiotensin system and inflammation update. Mol Cell Endocrinol 2021;529:111254. [PMID: 33798633 DOI: 10.1016/j.mce.2021.111254] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
65 Klimontov VV, Korbut AI, Orlov NB, Dashkin MV, Konenkov VI. Multiplex Bead Array Assay of a Panel of Circulating Cytokines and Growth Factors in Patients with Albuminuric and Non-AlbuminuricDiabetic Kidney Disease. J Clin Med 2020;9:E3006. [PMID: 32961903 DOI: 10.3390/jcm9093006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Chen J, Tsim KWK, Zhao YY. Editorial: Applications of Herbal Medicine to Control Chronic Kidney Disease. Front Pharmacol 2021;12:742407. [PMID: 34557105 DOI: 10.3389/fphar.2021.742407] [Reference Citation Analysis]
67 Tian J, Xiao Z, Wei J, Shan Y, Zeng D, Tao Y, Fang X, Tang C, Chen X, Li Y. NCTD Prevents Renal Interstitial Fibrosis via Targeting Sp1/lncRNA Gm26669 Axis. Int J Biol Sci 2021;17:3118-32. [PMID: 34421354 DOI: 10.7150/ijbs.59195] [Reference Citation Analysis]
68 Stenvinkel P, Chertow GM, Devarajan P, Levin A, Andreoli SP, Bangalore S, Warady BA. Chronic Inflammation in Chronic Kidney Disease Progression: Role of Nrf2. Kidney Int Rep 2021;6:1775-87. [PMID: 34307974 DOI: 10.1016/j.ekir.2021.04.023] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
69 Zhuang K, Jiang X, Liu R, Ye C, Wang Y, Wang Y, Quan S, Huang H. Formononetin Activates the Nrf2/ARE Signaling Pathway Via Sirt1 to Improve Diabetic Renal Fibrosis. Front Pharmacol 2020;11:616378. [PMID: 33519483 DOI: 10.3389/fphar.2020.616378] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
70 Jeon J, Lee K, Yang KE, Lee JE, Kwon GY, Huh W, Kim DJ, Kim YG, Jang HR. Dietary Modification Alters the Intrarenal Immunologic Micromilieu and Susceptibility to Ischemic Acute Kidney Injury. Front Immunol 2021;12:621176. [PMID: 33777001 DOI: 10.3389/fimmu.2021.621176] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
71 Li Y, Shen M, Ferens D, Broughton BRS, Murthi P, Saini S, Widdop RE, Ricardo SD, Pinar AA, Samuel CS. Combining mesenchymal stem cells with serelaxin provides enhanced renoprotection against 1K/DOCA/salt-induced hypertension. Br J Pharmacol 2021;178:1164-81. [PMID: 33450051 DOI: 10.1111/bph.15361] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Muñoz-Félix JM, Martínez-Salgado C. Dissecting the Involvement of Ras GTPases in Kidney Fibrosis. Genes (Basel) 2021;12:800. [PMID: 34073961 DOI: 10.3390/genes12060800] [Reference Citation Analysis]
73 Rodrigues-Diez RR, Tejera-Muñoz A, Orejudo M, Marquez-Exposito L, Santos L, Rayego-Mateos S, Cantero-Navarro E, Tejedor-Santamaria L, Marchant V, Ortiz A, Egido J, Mezzano S, Selgas R, Navarro-González JF, Valdivielso JM, Lavoz C, Ruiz-Ortega M. [Interleukin-17A: Possible mediator and therapeutic target in hypertension]. Nefrologia (Engl Ed) 2021;41:244-57. [PMID: 33775443 DOI: 10.1016/j.nefro.2020.11.009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
74 Zhang F, Zhou X, Zou H, Liu L, Li X, Ruan Y, Xie Y, Shi M, Xiao Y, Wang Y, Zhou Y, Wu Y, Guo B. SAA1 is transcriptionally activated by STAT3 and accelerates renal interstitial fibrosis by inducing endoplasmic reticulum stress. Exp Cell Res 2021;408:112856. [PMID: 34597680 DOI: 10.1016/j.yexcr.2021.112856] [Reference Citation Analysis]
75 Korin B, Chung JJ, Avraham S, Shaw AS. Preparation of single-cell suspensions of mouse glomeruli for high-throughput analysis. Nat Protoc 2021;16:4068-83. [PMID: 34282333 DOI: 10.1038/s41596-021-00578-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
76 Wang XH, Mitch WE, Price SR. Pathophysiological mechanisms leading to muscle loss in chronic kidney disease. Nat Rev Nephrol 2021. [PMID: 34750550 DOI: 10.1038/s41581-021-00498-0] [Reference Citation Analysis]
77 Higgins CE, Tang J, Higgins SP, Gifford CC, Mian BM, Jones DM, Zhang W, Costello A, Conti DJ, Samarakoon R, Higgins PJ. The Genomic Response to TGF-β1 Dictates Failed Repair and Progression of Fibrotic Disease in the Obstructed Kidney. Front Cell Dev Biol 2021;9:678524. [PMID: 34277620 DOI: 10.3389/fcell.2021.678524] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
78 Schunk SJ, Beisswenger C, Ritzmann F, Herr C, Wagner M, Triem S, Hütter G, Schmit D, Zewinger S, Sarakpi T, Honecker A, Mahadevan P, Boor P, Wagenpfeil S, Jörres R, Watz H, Welte T, Vogelmeier CF, Gröne HJ, Fliser D, Speer T, Bals R. Measurement of urinary Dickkopf-3 uncovered silent progressive kidney injury in patients with chronic obstructive pulmonary disease. Kidney Int 2021:S0085-2538(21)00663-3. [PMID: 34237325 DOI: 10.1016/j.kint.2021.06.029] [Reference Citation Analysis]
79 Grunenwald A, Roumenina LT, Frimat M. Heme Oxygenase 1: A Defensive Mediator in Kidney Diseases. Int J Mol Sci 2021;22:2009. [PMID: 33670516 DOI: 10.3390/ijms22042009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
80 Chen F, Gao Q, Wei A, Chen X, Shi Y, Wang H, Cao W. Histone deacetylase 3 aberration inhibits Klotho transcription and promotes renal fibrosis. Cell Death Differ 2021;28:1001-12. [PMID: 33024274 DOI: 10.1038/s41418-020-00631-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
81 Yu C, Xiong C, Tang J, Hou X, Liu N, Bayliss G, Zhuang S. Histone demethylase JMJD3 protects against renal fibrosis by suppressing TGFβ and Notch signaling and preserving PTEN expression. Theranostics 2021;11:2706-21. [PMID: 33456568 DOI: 10.7150/thno.48679] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
82 Midgley AC, Wei Y, Zhu D, Gao F, Yan H, Khalique A, Luo W, Jiang H, Liu X, Guo J, Zhang C, Feng G, Wang K, Bai X, Ning W, Yang C, Zhao Q, Kong D. Multifunctional Natural Polymer Nanoparticles as Antifibrotic Gene Carriers for CKD Therapy. J Am Soc Nephrol 2020;31:2292-311. [PMID: 32769144 DOI: 10.1681/ASN.2019111160] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
83 Martin WP, Chuah YHD, Conroy E, Reynolds AL, Judge C, López-Hernández FJ, le Roux CW, Docherty NG. Protocol for a preclinical systematic review and meta-analysis of pharmacological targeting of peroxisome proliferator-activated receptors in experimental renal injury. BMJ Open Sci 2021;5:e100240. [PMID: 34849404 DOI: 10.1136/bmjos-2021-100240] [Reference Citation Analysis]
84 Díaz R, Sandoval P, Rodrigues-Diez RR, Del Peso G, Jiménez-Heffernan JA, Ramos-Ruíz R, Llorens C, Laham G, Alvarez-Quiroga M, López-Cabrera M, Ruiz-Ortega M, Bajo MA, Selgas R. Increased miR-7641 Levels in Peritoneal Hyalinizing Vasculopathy in Long-Term Peritoneal Dialysis Patients. Int J Mol Sci 2020;21:E5824. [PMID: 32823722 DOI: 10.3390/ijms21165824] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
85 Ramil-Gómez O, Rodríguez-Carmona A, Fernández-Rodríguez JA, Pérez-Fontán M, Ferreiro-Hermida T, López-Pardo M, Pérez-López T, López-Armada MJ. Mitochondrial Dysfunction Plays a Relevant Role in Pathophysiology of Peritoneal Membrane Damage Induced by Peritoneal Dialysis. Antioxidants (Basel) 2021;10:447. [PMID: 33805753 DOI: 10.3390/antiox10030447] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Liu X, Luo D, Huang S, Liu S, Zhang B, Wang F, Lu J, Chen J, Li S. Impaired Nicotinamide Adenine Dinucleotide Biosynthesis in the Kidney of Chronic Kidney Disease. Front Physiol 2021;12:723690. [PMID: 34603081 DOI: 10.3389/fphys.2021.723690] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
87 Marchant V, Tejera-Muñoz A, Marquez-Expósito L, Rayego-Mateos S, Rodrigues-Diez RR, Tejedor L, Santos-Sanchez L, Egido J, Ortiz A, Valdivielso JM, Fraser DJ, López-Cabrera M, Selgas R, Ruiz-Ortega M. IL-17A as a Potential Therapeutic Target for Patients on Peritoneal Dialysis. Biomolecules 2020;10:E1361. [PMID: 32987705 DOI: 10.3390/biom10101361] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
88 Hassan NME, Shehatou GSG, Kenawy HI, Said E. Dasatinib mitigates renal fibrosis in a rat model of UUO via inhibition of Src/STAT-3/NF-κB signaling. Environ Toxicol Pharmacol 2021;84:103625. [PMID: 33617955 DOI: 10.1016/j.etap.2021.103625] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Alehagen U, Aaseth J, Alexander J, Brismar K, Larsson A. Selenium and Coenzyme Q10 Supplementation Improves Renal Function in Elderly Deficient in Selenium: Observational Results and Results from a Subgroup Analysis of a Prospective Randomised Double-Blind Placebo-Controlled Trial. Nutrients 2020;12:E3780. [PMID: 33317156 DOI: 10.3390/nu12123780] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
90 Yao SM, Zheng PP, Wan YH, Dong W, Miao GB, Wang H, Yang JF. Adding high-sensitivity C-reactive protein to frailty assessment to predict mortality and cardiovascular events in elderly inpatients with cardiovascular disease. Exp Gerontol 2021;146:111235. [PMID: 33453322 DOI: 10.1016/j.exger.2021.111235] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
91 Wonnacott A, Denby L, Jm Coward R, Fraser DJ, Bowen T. MicroRNAs and Their Delivery in Diabetic Fibrosis. Adv Drug Deliv Rev 2021;:114045. [PMID: 34767865 DOI: 10.1016/j.addr.2021.114045] [Reference Citation Analysis]
92 Gui T, Li Y, Zhang S, Alecu I, Chen Q, Zhao Y, Hornemann T, Kullak-Ublick GA, Gai Z. Oxidative stress increases 1-deoxysphingolipid levels in chronic kidney disease. Free Radic Biol Med 2021;164:139-48. [PMID: 33450378 DOI: 10.1016/j.freeradbiomed.2021.01.011] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
93 Rayego-Mateos S, Campillo S, Rodrigues-Diez RR, Tejera-Muñoz A, Marquez-Exposito L, Goldschmeding R, Rodríguez-Puyol D, Calleros L, Ruiz-Ortega M. Interplay between extracellular matrix components and cellular and molecular mechanisms in kidney fibrosis. Clin Sci (Lond) 2021;135:1999-2029. [PMID: 34427291 DOI: 10.1042/CS20201016] [Reference Citation Analysis]
94 Sun CM, Zhang WY, Wang SY, Qian G, Pei DL, Zhang GM. Fer exacerbates renal fibrosis and can be targeted by miR-29c-3p. Open Med (Wars) 2021;16:1378-85. [PMID: 34595351 DOI: 10.1515/med-2021-0319] [Reference Citation Analysis]
95 Cao JY, Wang B, Tang TT, Wen Y, Li ZL, Feng ST, Wu M, Liu D, Yin D, Ma KL, Tang RN, Wu QL, Lan HY, Lv LL, Liu BC. Exosomal miR-125b-5p deriving from mesenchymal stem cells promotes tubular repair by suppression of p53 in ischemic acute kidney injury. Theranostics 2021;11:5248-66. [PMID: 33859745 DOI: 10.7150/thno.54550] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
96 Van Nguyen T, Duc Ngo K, Hoang Thi M, Dam LTP, Huynh TQ. Evaluating the Serum Transforming Growth Factor-Beta 1 Level in Chronic Kidney Disease Caused by Glomerulonephritis. Nephro-Urol Mon 2021;13. [DOI: 10.5812/numonthly.113161] [Reference Citation Analysis]
97 Mok CC, Mohan C. Urinary Biomarkers in Lupus Nephritis: Are We There Yet? Arthritis Rheumatol 2021;73:194-6. [PMID: 32892509 DOI: 10.1002/art.41508] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
98 Chen Z, Peng H, Zhang C. Advances in kidney-targeted drug delivery systems. Int J Pharm 2020;587:119679. [PMID: 32717283 DOI: 10.1016/j.ijpharm.2020.119679] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
99 Li Y, Chakraborty A, Broughton BRS, Ferens D, Widdop RE, Ricardo SD, Samuel CS. Comparing the renoprotective effects of BM-MSCs versus BM-MSC-exosomes, when combined with an anti-fibrotic drug, in hypertensive mice. Biomed Pharmacother 2021;144:112256. [PMID: 34607108 DOI: 10.1016/j.biopha.2021.112256] [Reference Citation Analysis]
100 Rodrigues-Diez RR, Tejera-Muñoz A, Orejudo M, Marquez-Exposito L, Santos-Sanchez L, Rayego-Mateos S, Cantero-Navarro E, Tejedor-Santamaria L, Marchant V, Ortiz A, Egido J, Mezzano S, Selgas R, Navarro-González JF, Valdivielso JM, Lavoz C, Ruiz-Ortega M. Interleukin-17A: Potential mediator and therapeutic target in hypertension. Nefrologia 2021:S2013-2514(21)00057-2. [PMID: 34272191 DOI: 10.1016/j.nefroe.2021.06.003] [Reference Citation Analysis]
101 Julovi SM, Sanganeria B, Minhas N, Ghimire K, Nankivell B, Rogers NM. Blocking thrombospondin-1 signaling via CD47 mitigates renal interstitial fibrosis. Lab Invest 2020;100:1184-96. [PMID: 32366943 DOI: 10.1038/s41374-020-0434-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]